subject: To Revitalize The Pharmaceutical Industry, Last Bus Ride - Sheet Metal Parts - Machined Parts [print this page] No need to revitalize the pharmaceutical industry?
Have been rumors in the industry: pharmaceuticals, real estate, finance, energy, competition for the revitalization of the four major industries of the tenth plan, the ultimate medicine will take the lead out.
Should the pharmaceutical industry has been rejuvenated, has been surrounded by controversy.
The view was expressed that the financial crisis, the medical industry less affected, do not need to revitalize. Chinese Medicine & Health Products Import and Export Chamber of Commerce Vice-President Liu Zhang to this reporter that the 2008 Nianguang medicine an import and export volume reached 1.752 billion U.S. dollars, a record high, up 14.08 percent, higher than the 2007 growth rate of 3.5 points. Among them, imported 443 million U.S. dollars, up 24.46 percent, higher than in 2007, up 5.2 percentage points; exports 1.309 billion U.S. dollars, up 10.94 percent, higher than in 2007, up 2.8 percentage points, the trade surplus reached 866 million U.S. dollars.
SFDA south of Guangzhou, punctuation, executive vice president of medical information Co., Ltd. Bu Yong Zhang to the "China Times" reporter that the pharmaceutical industry are a part of the processing industry, and has issued nine industries compared to the upstream and downstream tension is not significant. Second, the new medical reform coming, corresponding to 830 billion total investment, naturally stimulating the pharmaceutical industry.
China Association for Pharmaceutical Industry R & D accounted for the Secretary-General on the text to the "China Times" reporter, said medical reform and medical support are two different things. Medical reform is to improve the universal quality of care, which is the industry's problems.
The former State Council Legislative Affairs Office Deputy Director of Health Department of Culture and Education, are Chinese Pharmaceutical Association Drug Policy Research Center Director Song Ruilin to the "China Times" reporter, said China has 1.3 billion people, the light on the domestic market can become a pillar industry of Chinese medicine, adapting and should boost the long-term to do.
China Chemical Pharmaceutical Industry Association, told this newspaper's reporters that the Secretary-General Zhou, medical reform and the pharmaceutical industry is not completely separated. Pharmaceutical industry's development is not completely independent, but also related to the policy level, health care standards. She said: "Now for the medical industry does need to have a 'plan', but this 'plan' should be a complete medical and health reform. As for this moment, we are also a letter to the Public Ministry to make policy recommendations to the relevant departments and bureaus, but on top of introduced the specific content of the policy, as the Association itself is not known at present on the. "
Informed sources: For the pharmaceutical industry, and now all the same attitude was, "Perhaps no mention of the revitalization, but also need to be adjusted, and now doing is not only immediate benefits, but more of a long-term plan - the concern is not a day or two , but for several decades for hundreds of years. "
If on adjusting the vision, the medicine of course, also need to "plan." These people said that in the current financial crisis in the background, you can cast fist of avenues are many. Is just as now, many foreign pharmaceutical companies are in production and cut jobs, this is a good opportunity for our integrated resources.
Innovation is a priority
Number of pharmaceutical industry sources told reporters that a few years ago, the pharmaceutical industry and the upper unit in charge has already reached a consensus, the pharmaceutical industry identified as a strategic industry. Such a strategy how to boost the industry and adjustment of the market with full competition in the industry is different.
China Pharmaceutical Enterprise Management Association, said a spokesman told reporters the current upload policy recommendations include: "To encourage innovation in medical enterprises; to encourage domestic standards with international standards; to encourage enterprises to go out ... ..."
The source said: "Innovation is a priority, although China is a major drug producing country, but the generic drug powerhouse. To change this situation, we rely on innovation. For innovative policy support should not be intermittent, in the hope to establish a sustainable medical innovation incentive mechanism. "
In the standard convergence, the above say, and now China's drug production, despite much progress, and international advanced standards, but still a gap. Certification levels are mainly the distance. Would be the first to encourage a number of enterprises in the standard to the FDA, the EU line. As long as the standard uniform for the promotion of economic self-explanatory.
Informed sources said that the standard has been doing the actual integration. State Food and Drug Administration and other departments have been to and including the World Health Organization and other organizations to communicate, the other party will also send experts to participate in our GMP inspections.
As to encourage enterprises to go global is a gradual process. Encouraged to take the lead in 100 companies go out, it is necessary to enter the world's leading pharmaceutical market, hope the Government will give some model support.
In an interview with a number of associations are reporters are proposals to raise the degree of industry concentration should also be included in the plan. "Although we are pharmaceutical companies too much excess capacity, but we do not add up to the national gross output value of a top-ranking U.S. business enterprises and enterprise."
Game is still going on
Although the parties have the intention, but the pharmaceutical industry to adjust to the final floor plan proposals, the actual will not be too easy.
Many in the industry authorities told reporters that many ministries can get involved management of pharmaceutical industries, but the actual amount of the regulatory authorities is not enough. Therefore, if the medicine to be out of the planning, coordination of various ministries and is bound to get a compromise after the final release, it took a longer time may be.
A person in charge of large pharmaceutical companies, told reporters have their own five-year plan, the new out of the "plan" how to be a problem with coordination. Should be based on long-term, both before and after, not the result of " ."
The number of reporters who have said that the medicine if you want out of the adjustment program, eventually catch the last train to revitalize industries, marked with "revival" word is not important.
Some analysts also questioned, contact the real estate industry rumors adjustment plan, if the so-called adjustment programs and the rescue plan is not much different from the case, will inevitably become less a "revitalization" should be short-term plans. The end result is the revitalization of industry, every industry wants to catch a ride into "industrial revitalization of 9 + n".
There is anecdotal evidence, energy, real estate, finance, medicine, war plans are in the tenth. In accordance with the logic of rumors, the four selected one after the other three are filtered down the industry how to do? "Or removed 'stimulus' to re-introduce the word?"
